Cargando…
Clinically relevant dual probe difference specimen imaging (DDSI) protocol for freshly resected breast cancer specimen staining
BACKGROUND: Re-excision rates following breast conserving surgery (BCS) remain as high as ~ 35%, with positive margins detected during follow-up histopathology. Additional breast cancer resection surgery is not only taxing on the patient and health care system, but also delays adjuvant therapies, in...
Autores principales: | House, Broderick J., Kwon, Marcus J., Schaefer, Jasmin M., Barth, Connor W., Solanki, Allison, Davis, Scott C., Gibbs, Summer L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059239/ https://www.ncbi.nlm.nih.gov/pubmed/33882909 http://dx.doi.org/10.1186/s12885-021-08179-8 |
Ejemplares similares
-
Optimizing fresh specimen staining for rapid identification of tumor biomarkers during surgery
por: Barth, Connor W., et al.
Publicado: (2017) -
Dual probe difference specimen imaging for prostate cancer margin assessment
por: Kwon, Marcus J., et al.
Publicado: (2023) -
Evaluating Receptor-Specific Fresh Specimen Staining for Tumor Margin Detection in Clinical Breast Specimens
por: Byrd, Brook K., et al.
Publicado: (2023) -
Diagnostic performance of receptor-specific surgical specimen staining correlates with receptor expression level
por: Schaefer, Jasmin M., et al.
Publicado: (2019) -
Topical dual-probe staining using quantum dot-labeled antibodies for identifying tumor biomarkers in fresh specimens
por: Meng, Boyu, et al.
Publicado: (2020)